Prostatic Hypertrophy, Benign

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

DrugDrug NameDrug Description
DB00590DoxazosinAn alpha-1 adrenergic receptor used to treat mild to moderate hypertension and urinary obstruction due to benign prostatic hyperplasia.
DB00706TamsulosinAn alpha-1A and alpha-1B adrenergic receptor antagonist used to treat benign prostatic hyperplasia, ureteral stones, prostatitis, and female voiding dysfunction.
DrugDrug NamePhaseStatusCount
DB00820Tadalafil1Completed1
DB00706Tamsulosin1Completed1
DB00898Ethanol1 / 2Completed1
DB06699Degarelix2Completed1
DB11231Lycopene2Completed1
DB08893Mirabegron2Active Not Recruiting1
DB01229Paclitaxel2Active Not Recruiting1
DB00862Vardenafil2Completed1
DB00346Alfuzosin3Completed1
DB00050Cetrorelix3Completed2
DB00050Cetrorelix3Terminated1
DB00590Doxazosin3Completed1
DB01216Finasteride3Completed1
DB05493NX-12073Completed1
DB00346Alfuzosin4Completed1
DB01028Methoxyflurane4Not Yet Recruiting1
DB06207Silodosin4Completed1
DB01591Solifenacin4Completed1
DB00706Tamsulosin4Completed1
DB00346AlfuzosinNot AvailableUnknown Status1
DB01126DutasterideNot AvailableCompleted1
DB00898EthanolNot AvailableCompleted1